Beta
Following decades of failures in Alzheimer's research, Eli Lilly & Co. could be on the cusp of a breakthrough. Lisa Jarvis reports on a new drug that could slow the onset of the disease.
How peptide injections became the answer to everything
11 min
The case for MDMA’s approval is riddled with problems
10 min
You know it’s a placebo. So why does it still work?
California promises better care for released inmates
5 min
Medical humanities and the specialist
19 min
Recovery from addiction is a journey. There’s no single solution
8 min